Non Viral In-Vivo CAR – Engineering with Episomal DNA: The Next Frontier for Off-the-Shelf & Scalable Cell Therapy
- Creating a third path to in-vivo CAR-T
- Highlight emerging preclinical evidence demonstrating feasibility and efficacy
New Data
This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.
Ran February, 2026
Ran February, 2026